Fig. 2

Predicted susceptibility of virus isolates from participants with viraemia receiving a tenofovir, emtricitabine and efavirenz combination regimen
Predicted susceptibility of virus isolates from participants with viraemia receiving a tenofovir, emtricitabine and efavirenz combination regimen